Systematic review of factors predictive of unfavourable vaginal bleeding in women of reproductive age using the contraceptive etonogestrel implant
暂无分享,去创建一个
[1] J. Sheeder,et al. The Etonogestrel Implant in Adolescents: Factors Associated with Removal for Bothersome Bleeding in the First Year after Insertion. , 2021, Journal of pediatric and adolescent gynecology.
[2] C. Aquilante,et al. Relationship Between Etonogestrel Concentrations and Bleeding Patterns in Contraceptive Implant Users. , 2019, Obstetrics and gynecology.
[3] I. Fraser,et al. Can initial vaginal bleeding patterns in etonogestrel implant users predict subsequent bleeding in the first two years of use? , 2019, Contraception.
[4] R. Ferriani,et al. Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial. , 2019, Contraception.
[5] A. Dempsey,et al. Prevalence of early discontinuation and associated factors among a retrospective cohort of etonogestrel contraceptive implant users , 2019, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[6] J. Garrett,et al. Etonogestrel-Releasing Contraceptive Implant for Postpartum Adolescents: A Randomized Controlled Trial. , 2017, Journal of pediatric and adolescent gynecology.
[7] D. Billings,et al. Six- and twelve-month documented removal rates among women electing postpartum inpatient compared to delayed or interval contraceptive implant insertions after Medicaid payment reform. , 2017, Contraception.
[8] P. Auinger,et al. Etonogestrel Implants in Adolescents: Experience, Satisfaction, and Continuation. , 2016, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[9] N. A. Rahman,et al. A clinical evaluation of bleeding patterns, adverse effects, and satisfaction with the subdermal etonogestrel implant among postpartum and non‐postpartum users , 2016, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[10] Moazzam Ali,et al. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls. , 2015, Human reproduction.
[11] M. Guida,et al. Bleeding profile in users of an etonogestrel sub-dermal implant: effects of anthropometric variables. An observational uncontrolled preliminary study in Italian population , 2015, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[12] C. Raker,et al. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding. , 2014, Contraception.
[13] Petra M. Casey,et al. Association of body mass index with removal of etonogestrel subdermal implant. , 2013, Contraception.
[14] Petra M. Casey,et al. Bleeding related to etonogestrel subdermal implant in a US population. , 2011, Contraception.
[15] I. Fraser,et al. The effects of Implanon® on menstrual bleeding patterns , 2008, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[16] P. Blumenthal,et al. Tolerability and clinical safety of Implanon® , 2008, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[17] A. Glasier,et al. Continuation rates of Implanon in the UK: data from an observational study in a clinical setting. , 2006, Contraception.
[18] S. Cotter,et al. Experience with Implanon® in a north-east London family planning clinic , 2004 .
[19] D. Machin,et al. The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction. , 1986, Contraception.